Persistent URL of this record https://hdl.handle.net/1887/3276514
Documents
-
- Download
- Inflammatory_bowel_diseases_27_1954
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Outcome of reverse switching from CT-P13 to originator infliximab in patients with inflammatory bowel disease
- All authors
- Mahmmod, S.; Schultheiss, J.P.D.; Bodegraven, A.A. van; Dijkstra, G.; Gilissen, L.P.L.; Hoentjen, F.; Lutgens, M.W.M.D.; Mahmmod, N.; Meulen-de Jong, A.E. van der; Smits, L.J.T.; Tan, A.C.I.T.L.; Oldenburg, B.; Fidder, H.H.
- Date
- 2021-12-01
- Journal
- Inflammatory Bowel Diseases
- Volume
- 27
- Issue
- 12
- Pages
- 1954 - 1962